期刊文献+

缺氧状态下人颞下颌关节滑膜成纤维细胞环氧合酶2的表达及意义 被引量:3

The role of hypoxia on expression of cyclooxygenase-2 in synovial fibroblasts derived from human temporomandular joint
原文传递
导出
摘要 目的研究缺氧对人颞下颌关节滑膜成纤维细胞环氧合酶2(COX2)表达的影响,并探讨其在颞下颌关节紊乱病(TMD)中的生物学作用。方法应用逆转录聚合酶链反应(RTPCR)和Western印迹检测缺氧不同时间段滑膜成纤维细胞COX2基因与蛋白质表达水平。采用酶联免疫吸附实验(ELISA)以及明胶酶谱法分别测定缺氧组、缺氧与COX2特异性抑制剂塞来昔布二者联合作用组前列腺素E2(PGE2),金属基质蛋白酶2、9(MMP2、MMP9)分泌量的变化,以常氧组为对照。结果(1)RTPCR测定细胞缺氧4、8hCOX2mRNA分别为1.51±0.34和1.39±0.57,与常氧组0.65±0.24和0.71±0.15比较,差异有统计学意义(均P<0.05)。(2)Western印迹测定细胞COX2蛋白表达,缺氧6h为0.29±0.06,12h为0.51±0.09,24h为0.68±0.11,而常氧组检测不出COX2蛋白(均P<0.01),表明缺氧条件下,细胞COX2蛋白表达呈时间依赖性增加。(3)ELISA测定细胞缺氧12h,释放的PGE2(7.6ng/ml±0.8ng/ml)显著高于常氧组(2.5ng/ml±0.4ng/ml,P<0.01);联合药物处理组(4.3ng/ml±0.4ng/ml)也显著低于缺氧组(P<0.05),表明细胞PGE2释放受抑制。(4)明胶酶谱法测定细胞缺氧12h,分泌的MMP2、MMP9高于常氧组,但在药物联合作用下,分泌能力减弱。结论组织缺氧是导致TMD的一个重要因素;缺氧状况下,人滑膜成纤维细胞可能通过增加COX2的表达来影响缺氧所致颞下颌关节病变进程。 Objective To investigate the effects of hypoxia on expression of COX-2 in synovial fibroblasts derived from human TMJ and to analyze the biological role of COX-2 on TMJ disorders. (Methods)Synovial fibroblasts were induced by hypoxia,COX-2 expression was determined by reverse transcription-polymerase chain reaction(RT-PCR)and Western blotting. Moreover,cells were stimulated by hypoxia or celecoxib or both of them,prostaglandin E2(PGE2)、matrix metalloproteinase 2、9(MMP-2、MMP-9)release was detected by enzyme-linked immunosorbent assay(ELISA)or gelatin zymography. Cells that were placed under normoxic conditons were used as controls. Results (1) In response to hypoxia,at 4 h(1.51±0.34)、8 h(1.39±0.57),significant elevation of COX-2 mRNA expression occurred,compared with data (0.65±0.24)、(0.71±0.15) under normoxic condition(both P<0.05).(2)The elevation of COX-2 protein was detectable at 6 h(0.29±0.06),12 h(0.51±0.09),24 h(0.68±0.11),contrasted with normoxia(all P<0.01). Therefore, it is suggested that COX-2 expression pattern present a time-dependent response to hypoxic conditions.(3)The concentration of PGE2 released by synovial fibroblasts under 12 h hypoxic condition (7.6 ng/ml±0.8 ng/ml) was significantly higher than those under normoxic condition (2.5 ng/ml±0.4 ng/ml,P<0.01)or in response to celecoxib combined with hypoxia (4.3 ng/ml±(0.4 ng/ml),P<0.05).(4) The amount of MMP-2、MMP-9 produced by synovial fibroblasts under 12 h hypoxic condition was upregulated compared with that under normoxia or in response to celecoxib combined with hypoxia. Conclusions Hypoxia is,at least in part,responsible for the pathogenesis of TMJ disorders, probably by promoting COX-2 expression of synovial fibroblasts derived from TMJ.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第25期1747-1751,共5页 National Medical Journal of China
基金 国家自然科学基金资助项目(30371549)
  • 相关文献

参考文献16

  • 1Smolian H, Aurer A, Sittinger M, et al. Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts. Biol Chem, 2001, 382:1491-1499.
  • 2Roshak A, Mochan E, Marshall LA. Suppression of human synovial fibroblast 85 kDa phospholipase A2 by antisense reduces interleukin-1 beta induced prostaglandin E2. J Rheumatol, 1996, 23:420-427.
  • 3Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum, 2003, 33:155-167.
  • 4Alaaeddine N, DiBattista JA, Pelletier JP, et al. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J Rheumatol, 1997, 24:1985-1994.
  • 5Edwards JC. Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res, 2000, 2:344-347.
  • 6Milam SB, Schmitz JP. Molecular biology of temporomandibular joint disorders: proposed mechanisms of disease. J Oral Maxillofac Surg, 1995, 53:1448-1454.
  • 7Stevens CR, Blake DR, Merry P, et al. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum, 1991, 34:1508-1513.
  • 8Bodamyali T, Stevens CR, Billingham ME, et al. Influence of hypoxia in inflammatory synovitis. Ann Rheum Dis, 1998, 57: 703-710.
  • 9郑祥毅,谢立平,秦杰,丁伟.环氧合酶-2基因在膀胱移行细胞癌组织中的表达[J].中华医学杂志,2003,83(19):1706-1707. 被引量:1
  • 10Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest, 2001, 107:1491-1495.

二级参考文献14

  • 1娄思权.骨关节炎的病理与发病因素[J].中华骨科杂志,1996,16(1):56-59. 被引量:229
  • 2王海鹰,周继林,洪民,王涪英,邓斌.咬合创伤颞颌关节软组织前列腺素 E_2 的分泌及变化[J].实用口腔医学杂志,1997,13(1):44-46. 被引量:7
  • 3O′Mahony CA, Beauchamp RD, Albo D, et al. Cyclooxygenase-2 alters transforming growth factor-beta 1 response during intestinal tumorigenesis. Surgery, 1999, 126:364-370.
  • 4Komhoff M, Guan Y, Shappell HW, et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol, 2000, 157:29-35.
  • 5Shirahama T, Arima J, Akiba S, et al. Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer, 2001, 92:188-193.
  • 6El-Sheikh SS, Madaan S, Alhasso A, et al. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. BJU Int, 2001, 88:921-927.
  • 7Kim SI, Kwon SM, Kim YS, et al. Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer. Urology, 2002, 60:816-821.
  • 8Bostrom PJ, Aaltonen V, Soderstrom KO, et al. Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cells. Pathology, 2001, 3:469-474.
  • 9Grubbs CJ, Lubet RA, Koki AT, et al. CeleCOXib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res , 2000, 60:5599-5602.
  • 10Shirahama T. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res,2000, 6:2424-2430.

共引文献3

同被引文献45

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部